PrEP_Clinicians_Guidelines_SA_March2016

Search

About PrEP
PrEP Planning A-Z
In Practice
Resources
Next-Gen
- The Dual Prevention Pill
- Research Pipeline
Populations Spotlight
- HIV Prevention among Pregnant and Breastfeeding People

About PrEP
PrEP Planning A-Z
In Practice
Resources
Next-Gen
- The Dual Prevention Pill
- Research Pipeline
Populations Spotlight
- HIV Prevention among Pregnant and Breastfeeding People

Search

South African Guidelines on the Safe Use of Pre-exposure Prophylaxis in Persons at Risk of Acquiring HIV-1 Infection (2016)

PrEP_Clinicians_Guidelines_SA_March2016

Sorry no page found

PrEP Watch is a one-stop for PrEP data, research, cost, access, implementation and advocacy efforts across the globe. Learn more about PrEP

Newsletter Sign-up

Connect with us

Email

Facebook

Twitter

About PrEP
PrEP Planning A-Z
In Practice
Resources
Next-Gen
- The Dual Prevention Pill
- Research Pipeline
Populations Spotlight
- HIV Prevention among Pregnant and Breastfeeding People

OPTIONS Accelerator

Fast tracking PrEP uptake through strategic communications and demand creation. Get started!

PrEPWatch was created in 2006 and is maintained by AVAC, a non-profit organization based in New York that uses education, policy analysis, advocacy and a network of global collaborations to accelerate the ethical development and global delivery of new and emerging HIV prevention options as part of a comprehensive and integrated pathway to global health equity. AVAC receives support for PrEPWatch from various sources including the Bill & Melinda Gates Foundation, the Children’s Investment Fund Foundation and USAID, via OPTIONS, PROMISE and MOSAIC projects. AVAC accepts no money from pharmaceutical companies, including Gilead Sciences and ViiV Healthcare. If you have a comment or suggestion regarding the content of this site, click here to contact us. Read our privacy policy.